Table 3.
Medication and compliance among patients in the noncommunicable disease (NCD) guidelines and mobile health (mHealth) records for refugees in Lebanon study.
|
Parameter |
Baseline |
Phase Ia | Phase IIb |
Change comparison |
|||||||
| n (%) | 95% CI | n (%) | 95% CI | n (%) | 95% CI | Phase I versus baseline | Phase II versus baseline | Phase II versus phase I | |||
| P value | P value | P value | |||||||||
| Hypertension medication | N=755 | N=697 | N=776 | ||||||||
| All hypertension patients prescribed medication for hypertensionc | 550 (72.8) | 69.5-76.0 | 554 (79.5) | 76.3-82.4 | 605 (78.0) | 74.9-80.8 | .003 | .02 | .48 | ||
| Not reported in patient recordc | 43 (5.7) | 4.2-7.6 | 92 (13.2) | 10.8-15.9 | 35 (4.5) | 3.2-6.2 | <.001 | .29 | <.001 | ||
| Self-reported hypertension medication | N=873 | N=652 | N=418 | ||||||||
| Ever prescribed medication | 873 (100) | 99.5-100 | 588 (90.2) | 87.6-92.4 | 414 (99.0) | 97.6-99.7 | <.001 | .004 | <.001 | ||
| N=754 | N=605 | N=413 | |||||||||
| Currently taking hypertension medicationd | 740 (98.1) | 96.9-99.0 | 570 (94.2) | 92.0-95.9 | 396 (95.9) | 93.5-97.6 | <.001 | .02 | .24 | ||
| Stopped taking medicines for 2+ weeks in the past 3 monthsd | 70 (9.3) | 7.3-11.6 | 49 (8.1) | 6.1-10.6 | 35 (8.6) | 6.0-11.7 | .45 | .69 | .80 | ||
| Noncompliancee | N=76 | N=50 | N=36 | ||||||||
| When medication was stopped | |||||||||||
| Stopped taking in Syria | 9 (11.8) | 5.6-21.3 | 10 (20.0) | 10.0-33.7 | 5 (13.9) | 4.7-29.5 | .21 | .76 | .47 | ||
| Taking in Syria, stopped in Lebanon | 36 (47.4) | 35.8-59.2 | 13 (26.0) | 14.6-40.3 | 15 (41.7) | 25.5-59.2 | .02 | .58 | .13 | ||
| Started taking in Lebanon but stopped | 31 (40.8) | 29.6-52.7 | 27 (54.0) | 39.3-68.2 | 16 (44.4) | 27.9-61.9 | .15 | .72 | .39 | ||
| Diabetes medication | N=460 | N=433 | N=468 | ||||||||
| % of all diabetes patients prescribed medication for diabetesc | 343 (74.6) | 70.3-78.5 | 347 (80.1) | 76.1-83.8 | 396 (84.6) | 81.0-87.8 | .047 | <.001 | .08 | ||
| Not reported in patient recordc | 28 (6.1) | 4.1-8.7 | 54 (12.5) | 9.5-16.0 | 16 (3.4) | 2.0-5.5 | .001 | .06 | <.001 | ||
| Self-reported diabetes medication | N=537 | N=394 | N=260 | ||||||||
| Ever prescribed medication | 536 (99.8) | 98.9-100 | 378 (95.9) | 93.5-97.7 | 257 (98.8) | 96.7-99.8 | <.001 | .07 | .03 | ||
| N=506 | N=384 | N=259 | |||||||||
| Currently taking diabetes medicationd | 488 (96.4) | 94.4-97.9 | 346 (90.1) | 86.7-92.9 | 240 (92.7) | 88.8-95.5 | <.001 | .02 | .26 | ||
| Stopped taking medicines for 2+ weeks in the past 3 monthsd | 38 (7.5) | 5.4-10.2 | 29 (7.6) | 5.1-10.7 | 14 (5.5) | 3.0-9.0 | .97 | .29 | .30 | ||
| Noncompliancee | N=43 | N=35 | N=15 | ||||||||
| When medication was stopped | |||||||||||
| Stopped taking in Syria | 6 (14.0) | 5.3-27.9 | 7 (20.0) | 8.4-36.9 | 5 (33.3) | 11.8-61.6 | .48 | .10 | .32 | ||
| Taking in Syria, stopped in Lebanon | 22 (51.2) | 35.5-66.7 | 9 (25.7) | 12.5-43.3 | 3 (20.0) | 4.3-48.1 | .02 | .04 | .67 | ||
| Started taking in Lebanon but stopped | 15 (34.9) | 21.0-50.9 | 19 (54.3) | 36.6-71.2 | 7 (46.7) | 21.3-73.4 | .09 | .43 | .63 | ||
aGuideline implementation.
bmHealth implementation.
cAs reported in patient health records.
dAmong those prescribed medication.
eAmong only patients that stopped taking medication in the past 3 months.